VLPs Derived from the CCMV Plant Virus Can Directly Transfect and Deliver Heterologous Genes for Translation into Mammalian Cells

Biomed Res Int. 2019 Oct 29:2019:4630891. doi: 10.1155/2019/4630891. eCollection 2019.

Abstract

Virus-like particles (VLPs) are being used for therapeutic developments such as vaccines and drug nanocarriers. Among these, plant virus capsids are gaining interest for the formation of VLPs because they can be safely handled and are noncytotoxic. A paradigm in virology, however, is that plant viruses cannot transfect and deliver directly their genetic material or other cargos into mammalian cells. In this work, we prepared VLPs with the CCMV capsid and the mRNA-EGFP as a cargo and reporter gene. We show, for the first time, that these plant virus-based VLPs are capable of directly transfecting different eukaryotic cell lines, without the aid of any transfecting adjuvant, and delivering their nucleic acid for translation as observed by the presence of fluorescent protein. Our results show that the CCMV capsid is a good noncytotoxic container for genome delivery into mammalian cells.

MeSH terms

  • Animals
  • Bromovirus / genetics*
  • Capsid Proteins / genetics
  • Cell Line
  • Eukaryotic Cells / virology
  • Gene Transfer Techniques*
  • Genes, Reporter / genetics
  • Green Fluorescent Proteins / genetics
  • HeLa Cells
  • Humans
  • Plant Viruses / genetics*
  • Transfection / methods
  • Vaccines, Virus-Like Particle / genetics*
  • Virus Assembly / genetics

Substances

  • Capsid Proteins
  • Vaccines, Virus-Like Particle
  • Green Fluorescent Proteins